Akums Drugs & Pharma P/E Ratio

Current P/E Ratio
39.3
High Valuation
Very High - High growth expectations or significantly overvalued

Akums Drugs & Pharma P/E ratio. Akums Drugs & Pharma (AKUMS) P/E ratio is 39.3 (High), EPS (TTM) ₹16.67, current price ₹680.20 on NSE vs historical average P/E of 30.46 (100.0th percentile) — Very High - High growth expectations or significantly overvalued. Examine Akums Drugs & Pharma quarterly financials for recent quarterly revenue, profit and EPS trends.

Current Valuation Metrics

P/E Ratio 39.3
Current Price ₹680.20
EPS (TTM) ₹16.67
Exchange NSE

Valuation Signal

Signal Overvalued
Historical Avg 30.46
Historical Range 30.46 - 30.46
Percentile 100.0%

Sector Context

Sector Average 54.83
Sector Median 31.4
Sector Rank #11 of 200
Sector Percentile 5.5%

Earnings Breakdown (TTM)

TTM EPS ₹24.36
Mar 2026 ₹5.53
Jun 2026 ₹6.53

AKUMS P/E Ratio — Valuation Signal & Historical Context

Akums Drugs & Pharma P/E 39.3 vs historical average 30.46, range 30.46–30.46 — signal: Overvalued. Also explore Akums Drugs & Pharma share price performance to track price trends across different timeframes.

  • Stock appears overvalued with PE of 39.3, suggesting caution for new investments
  • Current PE is 29.0% above historical average
  • Trading at discount to sector average PE of 54.83

Akums Drugs & Pharma P/E Ratio Historical Trend

AKUMS annual price-to-earnings ratio — 1 years, EPS and year-end price. Current P/E 39.3 vs historical average 30.46. For live price, revenue and the complete fundamental profile, see Akums Drugs & Pharma stock price NSE.

AKUMS Historical P/E Ratio — EPS, Year-End Price & Valuation

Akums Drugs & Pharma annual P/E ratio, EPS (₹), year-end price and valuation category on NSE.

Year P/E Ratio EPS (₹) Year-end Price (₹) Exchange Valuation
2025 30.46 20.78 ₹632.90 NSE High

AKUMS vs Healthcare Peers — P/E Ratio Comparison

Akums Drugs & Pharma P/E 39.3 vs Healthcare average 54.83, median 31.4 — range 2.02–722.21.

Sector Average
54.83
Sector Median
31.4
Lowest P/E
2.02
Highest P/E
722.21
Companies
200
Company Symbol P/E Ratio Market Cap (₹ Cr) Valuation
Sunrest Lifescience SUNREST 2.02 ₹60 Low
Murae Organisor MURAE 2.86 ₹41 Low
Phaarmasia PHRMASI 3.33 ₹55 Low
Sun Pharma Advanced Rese… SPARC 3.86 ₹6,006 Low
Dipna Pharmachem DPL 3.97 ₹11 Low
JFL Life Sciences JFLLIFE 5.05 ₹65 Low
Royal Sense ROYAL 5.39 ₹40 Low
Kabra Drugs KABRADG 5.47 ₹41 Low
GKB Ophthalmics GKB 5.85 ₹32 Low
Colinz Laboratories COLINZ 6.31 ₹18 Low